Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a
Journal Title: Pakistan Biomedical Journal - Year 2019, Vol 2, Issue 1
Abstract
Chronic hepatitis C infection has created a huge burden of disease causing serious health effects. The combination therapy used to treat hepatitis C virus (HCV) infection includes Pegylated interferon and Ribavirin. As cholesterol biosynthesis plays a pivotal role in HCV replication, the use of various statins has been associated with higher sustained viral response. Objective: To compare the efficacy of atorvastatin plus pegylated interferon and ribavirin versus pegylated interferon and ribavirin alone in patients of chronic hepatitis C with genotype-3a Methods: This Randomized controlled trial was conducted at outpatient department, Mayo Hospital Lahore for six months i.e. May to November 2017. After ethical approval, 60 patients of ages 25 to 55 years of either gender with chronic hepatitis C with genotype 3a were included in the study. Informed consent was taken from all patients. Then patients were randomly allocated into two groups “A” and “B” using random number table. Patients in Group A received standard of care treatment for chronic hepatitis C i.e. pegylated interferon and ribavirin while the patients in Group B also received tab atorvastatin along with the standard treatment. Patients were follow up for 4 week. Blood samples were collected and HCV RNA detection. All this information were entered in proforma Results: In standard therapy group, the mean age of patients was 39.50±8.39years. In atorvastatin plus standard therapy group, the mean age of patients was 34.30±6.78years. In standard therapy group, there were 25 (83.3%) males and 5 (16.7%) females. In atorvastatin plus standard therapy group, there were 16 (53.3%) males and 14 (46.7%) females. After 4 weeks, Rapid Virological Response (RVR) was achieved in 4 (13.3%) patients in standard therapy group while in 14 (46.7%) in atorvastatin plus standard therapy group. The difference was significant (p<0.05) Conclusions: Atorvastatin in combination with Pegylated interferon and ribavirin have better efficacy as compared to Pegylated interferon & ribavirin alone in chronic hepatitis C-3a.
Authors and Affiliations
Waqas Gulzar1, Zafar Niaz2*, Sami Ullah Mumtaz2, Somia Iqtadar2, Tayyeba Komal3 and Sajid Abaidullah2
Keywords
Related Articles
- EP ID EP694173
- DOI https://doi.org/10.52229/pbmj.v2i1.28
- Views 123
- Downloads 0
Multivariate Analysis of Rotifers Community from Safari Zoo Lake Lahore, Pakistan
Rotifers are zooplanktons that react more sharply to the environmental changes. Objective: To better understand the community composition of rotifers in Safari Zoo Lake, Lahore, Pakistan Methods: We collected 16...
Varietal comparison of proximate composition and mineral profiling of Pakistan native barberry powder
Berberis Vulgaris fruit (barberry) also commonly known as “zereshk” is one of the world’s renowned medicinal plant with highly nutritious and therapeutic values, world widely. It is an elongated, 8-10mm long, bright red...
Novel Bioactive Compound Production by Microbial Biota: Potential Antimicrobials
Man is always trying to make his life easier and accomplished. He has faced mass destruction in history due to epidemics like small pox, malaria and plague. In order to combat diseases, exploration of man led him to sear...
Arrhythmias after Implantation of the Left Ventricular Assisted Device
Cardiac arrhythmias has been frequently reported after left ventricular assist devices implantation but currently literature shows no sufficient information on cardiac arrhythmias Objective: The aim of this study w...
Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a
Chronic hepatitis C infection has created a huge burden of disease causing serious health effects. The combination therapy used to treat hepatitis C virus (HCV) infection includes Pegylated interferon and Ribavirin. As c...